How many drugs treat Histiocytic lymphoma?

Drug Landscape tracks 2 marketed treatments for Histiocytic lymphoma (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/histiocytic-lymphoma.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Histiocytic lymphoma — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Histiocytic lymphoma (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Histiocytic lymphoma, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Cytoxan (Lyophilized)	cyclophosphamide	Baxter	Alkylating agent	Tumor cell DNA		1959-01-01
Cyclophosphamid	Cyclophosphamid	Zhejiang University		Cytochrome P450 3A4

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Baxter · 2 drugs in Histiocytic lymphoma
Zhejiang University · 1 drug in Histiocytic lymphoma

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Histiocytic lymphoma:

Cite this brief

Drug Landscape (2026). Histiocytic lymphoma — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/histiocytic-lymphoma. Accessed 2026-06-10.

Histiocytic lymphoma full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing